Postmortem studies indicated increased levels of MCP-1 and Interleukin-1β (IL-1β) in parietal cortex and a trend toward increased levels of IL-1β and MCP-1 in frontal cortex in older adults with amyloid beta deposition compared to age-matched individuals without amyloid [80]. The gene discussed is CCL2; the disease is amyloidosis.